Skip to main content
SpringerPlus

Table 3 Reasons for NOAC preference

From: Direct new oral anticoagulants: follow-up, guidelines and bleeding complications in general practice—a survey of Swiss general internal medicine practitioners

Reasons

Number (%)

Prescription by specialists

37 (69.8%)

Evidence

27 (50.9%)

Prevalence

25 (47.2%)

Patient’s profile

13 (30.2%)

Easier dosing OD

9 (17.0%)

Patient’s choice

7 (13.2%)

Personal experience

3 (5.7%)

  1. Multiple answers possible. n = 53. Absolute number (%)
Back to article page